McGovern Institute for Brain Research

Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines

Retrieved on: 
Thursday, February 16, 2023
Research, Genetics, Clinical Trials, Health Technology, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Messenger, MIT, Protein, James, Broad Institute, McGovern Institute for Brain Research, Tissue, Lux Capital, ARCH Venture Partners, Retrotransposon, Patient, Alnylam Pharmaceuticals, Harvard University, Howard Hughes Medical Institute, Liver, Doctor of Philosophy, GV, Therapy, Disease, Vertex Pharmaceuticals, RNA interference, Enzyme, PNP, Pharmaceutical industry, Vaccine, Management, Neuroscience

Aera Therapeutics announced its launch today with a vision to harness its proprietary delivery platform to unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas.

Key Points: 
  • Aera Therapeutics announced its launch today with a vision to harness its proprietary delivery platform to unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas.
  • The company has raised $193 million in combined Series A and B financings led by ARCH Venture Partners, GV and Lux Capital.
  • “Challenges remain with current delivery approaches, and genetic medicines applications have been generally restricted to the liver and ex vivo settings.
  • “Aera’s endogenous human PNP platform represents an exciting new approach for the delivery of genetic medicines.

The Termeer Foundation Selects Inaugural Termeer Scholars: CRISPR Pioneers and Biotechnology Innovators Omar Abudayyeh and Jonathan Gootenberg of MIT to Receive $50,000 Grant

Retrieved on: 
Wednesday, June 22, 2022
Health, Infectious Diseases, General Health, Research, Science, Pharmaceutical, Biotechnology, Doctor of Philosophy, Harvard University, Broad Institute, Microbiology, Molecular biology, Therapy, Henri Termeer, Forbes, McGovern Institute for Brain Research, Biochemistry, Systems biology, Drug development, Ageing, Business Insider, Degenerative disease, Paul Gootenberg, Seed, MIT, Enzyme, Business, Entrepreneurship, CRISPR, Biotechnology, Director, Foundation, Research, LinkedIn, Massachusetts Institute of Technology, Chief executive officer, MIT Technology Review, MD, Health, Patient, Lists of diseases, Board, Organization, Pharmaceutical industry, Management, Mentorship, Technology, Science

These tools have been adopted by researchers over the world and formed the basis for four companies that Omar and Jonathan have co-founded.

Key Points: 
  • These tools have been adopted by researchers over the world and formed the basis for four companies that Omar and Jonathan have co-founded.
  • The Termeer Foundation is working to improve the long odds of biotechnology by identifying and supporting future biotech leaders; if we help them succeed as leaders, we can help their innovations reach patients.
  • "The Termeer Foundation is committed to championing emerging biotechnology leaders and finding people who want to solve the biggest problems in human health, said Belinda Termeer, President of The Termeer Foundation.
  • Abudayyeh and Gootenberg were honored at the Termeer Foundations annual dinner in Boston on June 16, 2022.

Octant Raises $80 Million Series B Round to Support Expansion of Next-Generation Drug Discovery Platform, Announces Collaboration with Bristol Myers Squibb and Key Appointments

Retrieved on: 
Thursday, April 21, 2022
Biotechnology, Other Health, Health, Pharmaceutical, Clinical Trials, Protein, Board, McGovern Institute for Brain Research, Howard Hughes Medical Institute, MIT, Berkeley, Genetics, Coronavirus Scientific Advisory Board (Turkey), Plexxikon, Genentech, Research, Genomics, Yale University, Psychiatry, Cognitive science, Elan, Doctor of Philosophy, Drug discovery, Stanford University, Lists of diseases, Patient, Harvard College, Series, Allen & Company, CSO, Genome, Harvard University, Informatics, Physics, Molecular Discovery, DMS, Bristol Myers Squibb, Biology, Eukaryote, Partnership, University, James, Senior, CRISPR, Partner (business rank), Therapy, Broad Institute, Biological engineering, Synthetic biology, Pharmaceutical industry, Fine chemical, Chemistry, Brain, Octant, Neuroscience

In addition to Catalio, the Series B financing included participation from Bristol Myers Squibb, and existing investors Andreessen Horowitz Bio Fund, Allen & Co., and 50 Years VC.

Key Points: 
  • In addition to Catalio, the Series B financing included participation from Bristol Myers Squibb, and existing investors Andreessen Horowitz Bio Fund, Allen & Co., and 50 Years VC.
  • Octant also plans to develop multiple additional therapeutic programs in small molecule chaperone therapies for rare genetic diseases.
  • Immunogenetics and immunopharmacology are among the most complex areas in biology and drug discovery, with potential to impact countless patients, continued Kosuri.
  • As Chief Scientific Officer, Rick Artis will be responsible for Octant's chemistry function and drug discovery and development programs.

Archbold Biological Station Receives $2 Million Gift From K. Lisa Yang Supporting Florida Scrub-Jay Research

Retrieved on: 
Tuesday, November 30, 2021
Science, Other Philanthropy, Agriculture, Research, Natural Resources, Environment, Philanthropy, Fund Raising, Research, McGovern Institute for Brain Research, Cornell Lab of Ornithology, Aphelocoma, MIT, Hock, Behavior, Technology, Bird, Autism, Ecology, Florida scrub jay, Devereux Foundation, Leadership, Stanford University School of Medicine, Wall Street, Program, Queen's University Biological Station, Animal, Family, Cornell University, DNA, Twitter, Genetics, Columbia University, Life, Board of directors, Board, Avian ecology field methods, Knowledge, Instagram, Columbia University Graduate School of Journalism, Director, Icon, Harvard University, Science, Archbold Biological Station, Multimedia, River source, Medical device, Management, Forestry

Archbold Biological Station soars to new heights with a generous $2 million dollar gift from philanthropist K. Lisa Yang establishing the John W. Fitzpatrick Director of Avian Ecology.

Key Points: 
  • Archbold Biological Station soars to new heights with a generous $2 million dollar gift from philanthropist K. Lisa Yang establishing the John W. Fitzpatrick Director of Avian Ecology.
  • The endowment will enhance bird research at Archbold, with a focus on the threatened Florida Scrub-Jay.
  • Her gift builds on Archbold's 50-year investment in Florida Scrub-Jay research, which has advanced studies of animal behavior and ecology around the world.
  • It will generate annual funding that will enhance bird research at Archbold and propel our science into the future.

Labroots Announces its CRISPR Virtual Meeting, Scheduled on September 29, 2021

Retrieved on: 
Thursday, September 23, 2021
Social media, University, News, Gene editing, Organic acid, MIT, McGovern Institute for Brain Research, Continuing education, Biology, Leukemia, Health, IMTEK, Method, Cas, Ethics, Science, COVID-19, Social, Technology, Fellows, Severe acute respiratory syndrome coronavirus 2, Research, Single-cell analysis, Learning, Enzyme, Department, Pharmaceutical industry, Medical device, Online shopping

YORBA LINDA, Calif., Sept. 23, 2021 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is delighted to announce its 4th annual CRISPR virtual event scheduled on September 29th, 2021.

Key Points: 
  • YORBA LINDA, Calif., Sept. 23, 2021 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is delighted to announce its 4th annual CRISPR virtual event scheduled on September 29th, 2021.
  • CRISPR 2021 will bring together over 12,000 attendees to highlight the cutting-edge advancements in this exciting and rapidly emerging field.
  • Dr. Dincer will discuss during his keynote presentation titled, CRISPR Powered Biosensors, the current CRISPR powered biosensing technologies and their challenges and future perspectives.
  • Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more.

Pinterest CEO Ben Silbermann Partners With Leading Doctors and Scientists to Launch How We Feel, an App That Lets Everyone Help Track and Fight COVID-19

Retrieved on: 
Thursday, April 2, 2020
Software, Health, Other Education, Infectious diseases, Technology, Philanthropy, Mobile, Wireless, Foundation, Operating systems, Computer architecture, Computing, Smartphones, Mobile app, McGovern Institute for Brain Research, Android, IOS

The How We Feel app is available for download today in the U.S. on iOS and Android, and via the web at http://www.howwefeel.org .

Key Points: 
  • The How We Feel app is available for download today in the U.S. on iOS and Android, and via the web at http://www.howwefeel.org .
  • How We Feel does not ask users to create an account, and doesnt ask for a name, phone number or email address.
  • The aggregated information will be shared with select scientists, public health professionals, and doctors who need more data to continue fighting the spread of COVID-19.
  • Scientific, public health and biomedical collaborators include:
    James and Patricia Poitras Professor of Neuroscience, McGovern Institute for Brain Research, MIT